Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

Share Price is delayed by 15 minutes
Get Live Data
94.50    2.30 (2.49%)
Bid:
94.10
Ask:
94.40
Spread: 0.30 (0.319%)
Market Cap: £348.08m
CCR Live PriceLast checked at - London Stock Exchange

Intraday C&C Group Share Chart

Trading Statement

13 Mar 2018 07:00

C&C Group Plc

(β€œC&C” or the β€œGroup”)

Period end trading update for the 12 months ended 28 February 2018

Dublin, London | 13 March, 2018: C&C Group plc, the manufacturer, marketer and distributor of branded cider, beer, wine and soft drinks, today issues its period end trading update for the 12 months to 28 February, 2018 (β€œFY18”). Preliminary results for FY18 will be announced on 16 May, 2018.

Summary

Despite weather-related disruption, trading and cash generation was broadly in line with management expectations Group operating profit is anticipated to be around €86 million for the full year, with Admiral Taverns contributing an additional €1.1 million to Group earnings Cash conversion is expected to be within our guidance range at c.60% of EBITDA Tennent’s in Scotland and super-premium brands grew revenues strongly Magners returned to volume growth with momentum building through the first year of our cider distribution partnership with AB InBev Resilient trading in off-trade and on-trade packaged in Ireland, but competitive pressures in draught remain intense Currency translation of c. €3 million and one-off impacts relating to the new AB InBev arrangements negatively impacted full year profitability

Market Review

In Scotland, Tennent’s grew share in the important IFT and retail channels in the second half, outperforming the overall GB beer market which declined -2%1. Net sales revenues for Tennent’s are expected to be +3% for FY18 (FY17: -4%). Our wholesale business in Scotland is also performing strongly growing volumes +2% (FY17: -4%), revenues and share in FY18.

Our expanded distribution agreement with AB InBev for our cider portfolio in the UK gathered momentum in the second half. Magners was +9% in the second half (H1: -6%) benefitting from the launch of Magners Dark Fruit, increased participation in major retailers’ Christmas promotions and incremental on-trade and wholesale distribution. Magners will post flat volumes for the full year FY18 (FY17: +13%) against a GB cider market that was also flat2.

In Ireland, the trading environment remains highly competitive, both within long alcoholic drinks and from other categories. Bulmers (incl. Outcider) grew volumes and share in the off-trade and maintained share in the packaged on-trade segment. In an overall cider category that declined -1%3, Bulmers brand volumes were down c.-6% for FY18 (FY17: +3%) reflecting the loss of on-trade draught distribution points. As highlighted in our first half results, revenues and profitability in Ireland were also negatively impacted by reduced volumes in our wholesale business and the reversion of certain customers to direct supply from AB InBev.

Our super-premium portfolio made further progress across all our domestic markets in the second half. Volumes will exceed 100kHL in FY18, representing c.4% of Group branded volumes. Organic volume growth from brands such as Menabrea and Heverlee, increased +41% for full year FY18 (FY17 +60%). In addition, we saw strong first year contributions from our recently acquired craft brands 5Lamps in Ireland and Orchard Pig in the UK.

In Export territories volume growth is expected to be +2% (FY17: +4%) for FY18. Good growth in Magners and Tennent’s in Asia Pacific was off-set by slower growth in cider in Europe attributable to increased parallel import activity and supply chain disruptions in our nascent African business.

In the US, Magners and Wyders stabilised through the course of FY18, while Woodchuck and our other national brands lost volume and share, reflecting an overall cider category in high single-digit decline. In February 2018, we announced that our US subsidiary Vermont Hard Cider would resume full responsibility for the sales and marketing of the Group’s cider portfolio in the US.

Cash and balance sheet

Cash generation remains robust, with cash conversion for FY18 expected to be within our long term guidance range at c.60% of EBITDA (FY17: 53%).

During the year we made a €42 million investment in the UK on-trade through Admiral Taverns and invested a further €12 million on our craft brand portfolio. In addition, we returned €73 million to shareholders through a combination of share buy-back and dividends.

Outlook

The performance of our Scottish businesses and our growing super-premium portfolio has been encouraging in FY18 and both are well positioned to deliver further value growth in FY19. The introduction of minimum unit pricing of alcohol in Scotland this year may result in some short-term market disruption, but longer term will bring value to the category. While competitive pressures remain in Ireland, we expect performance to improve next year. In the UK, our strengthened route-to-market platforms of Admiral Taverns and AB InBev are now well-embedded. The outlook for the UK high street and consumer spending remains challenging but our brands and the predominantly wet-led, community pubs we serve are proving resilient.

1. GB on and off-trade beer volumes (CGA and Nielsen) – 12 mth MAT to 31 December(CGA)/January(Nielsen) 2017/182. GB on and off-trade cider volumes (CGA and Nielsen) – 12 mth MAT to 31 December(CGA)/January(Nielsen) 2017/183. ROI on and off-trade cider volumes (Nielsen Ireland databases) – 12mth MAT to 31 December 2017

-ENDS-

Contacts

C&C Group plcStephen Glancey, Chief ExecutiveJonathan Solesbury, Chief Financial OfficerJoe Thompson, Investor RelationsTel: + 44 7980 844 580

Investors, Analysts & Irish MediaMark Kenny/Jonathan NeilanFTI ConsultingTel: +353 1 765 0886Email: CandCGroup@fticonsulting.com

UK & International MediaTim RobertsonNovella CommunicationsTel: +44 203 151 7008Email: TimR@novella-comms.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20180313005386/en/

Copyright Business Wire 2018

Date   Source Headline
26th Jan 20233:45 pmRNSHolding(s) in Company
17th Jan 20232:40 pmRNSDirector/PDMR Shareholding
13th Jan 20237:00 amBUSTrading Statement
16th Dec 20222:45 pmRNSDirector/PDMR Shareholding
15th Dec 20223:15 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amBUSStatement re Directorate Change and Board Committee Update
5th Dec 20224:30 pmRNSHolding(s) in Company
2nd Dec 20222:28 pmRNSDirector Declaration
30th Nov 20224:45 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSBlock listing Interim Review
21st Nov 202212:00 pmRNSDirector/PDMR Shareholding
18th Nov 20227:10 amRNSDirector Declaration
9th Nov 20229:15 amRNSHolding(s) in Company
14th Sep 20227:00 amBUSStatement re H1 pre-close Trading Statement
16th Aug 20222:15 pmRNSDirector/PDMR Shareholding
28th Jul 202211:00 amRNS2021 Long Term Incentive Plan (‘LTIP’) Awards
26th Jul 20223:15 pmRNSDirector/PDMR Shareholding
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
18th Jul 20224:00 pmRNSHolding(s) in Company
15th Jul 20225:05 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResult of AGM
7th Jul 20227:00 amBUSAGM Statement
29th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20225:39 pmRNSHolding(s) in Company
15th Jun 20225:10 pmRNSDirector/PDMR Shareholding
10th Jun 20227:00 amRNSDirector/PDMR Shareholding
8th Jun 20228:30 amRNSAnnual Report and Notice of AGM
31st May 20224:45 pmRNSHolding(s) in Company
31st May 20227:00 amRNSBlock listing Interim Review
30th May 202210:00 amRNSHolding(s) in Company
24th May 20225:45 pmRNSHolding(s) in Company
17th May 20222:00 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amBUSFinal Results
3rd May 20224:15 pmRNSDirector/PDMR Shareholding
16th Mar 20222:30 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amBUSTrading Statement
16th Feb 20223:45 pmRNSDirector/PDMR Shareholding
15th Feb 20222:45 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Jan 20227:00 amBUSTrading Statement
20th Dec 20213:00 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amBUSStatement re Notice of Capital Markets Day
3rd Dec 20219:35 amRNSHolding(s) in Company
1st Dec 202110:45 amRNSDirector Declaration
30th Nov 20217:00 amRNSBlock listing Interim Review
17th Nov 202111:45 amRNSDirector/PDMR Shareholding
29th Oct 20213:47 pmRNSHolding(s) in Company
28th Oct 20217:00 amBUSHalf-year Report
19th Oct 20215:00 pmRNSDirector/PDMR Shareholding
12th Oct 20215:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.